Mr Matthew C Wilks, PA-C | |
4319 Papermill Dr, Knoxville, TN 37909-2069 | |
(865) 470-4127 | |
(951) 257-0143 |
Full Name | Mr Matthew C Wilks |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Experience | 23 Years |
Location | 4319 Papermill Dr, Knoxville, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023062569 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | PA1069 (Tennessee) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Knoxville Center For Dermatology And Plastic Surgery Pl | 9436406717 | 4 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
Researchers at the University of Gothenburg, Sweden, and the Chalmers University of Technology, Sweden, demonstrate that an altered gut microbiota in humans is associated with symptomatic atherosclerosis and stroke.
For pacemakers and other implantable medical devices there are three key factors: extreme reliability, small size, and long longevity. In the EU project DeSyRe, researchers tackle these issues with a new approach: building a reliable system on unreliable components. Ioannis Sourdis, project leader, today explains the DeSyRe's approach in a tutorial on "Hardware and software design and verification for safety critical electronic systems" during the DATE 2012 conference in Dresden.
Actelion Pharmaceuticals US, Inc. today announced the commercial availability of Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, for the treatment of primary pulmonary hypertension and pulmonary hypertension associated with scleroderma spectrum of disease in NYHA Class III and Class IV patients.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Matthew C Wilks, PA-C Po Box 11268, Knoxville, TN 37939-1268 Ph: (865) 584-7376 | Mr Matthew C Wilks, PA-C 4319 Papermill Dr, Knoxville, TN 37909-2069 Ph: (865) 470-4127 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
Researchers at the University of Gothenburg, Sweden, and the Chalmers University of Technology, Sweden, demonstrate that an altered gut microbiota in humans is associated with symptomatic atherosclerosis and stroke.
For pacemakers and other implantable medical devices there are three key factors: extreme reliability, small size, and long longevity. In the EU project DeSyRe, researchers tackle these issues with a new approach: building a reliable system on unreliable components. Ioannis Sourdis, project leader, today explains the DeSyRe's approach in a tutorial on "Hardware and software design and verification for safety critical electronic systems" during the DATE 2012 conference in Dresden.
Actelion Pharmaceuticals US, Inc. today announced the commercial availability of Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, for the treatment of primary pulmonary hypertension and pulmonary hypertension associated with scleroderma spectrum of disease in NYHA Class III and Class IV patients.
› Verified 5 days ago
Michael Patrick Flynn, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 501 20th St Ste 503, Knoxville, TN 37916 Phone: 865-331-4321 Fax: 865-331-4320 | |
Dakotah Asher, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4629 Mill Branch Ln, Knoxville, TN 37938 Phone: 865-201-1756 Fax: 865-922-1659 | |
Matthew Cox, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 280 Fort Sanders West Blvd Ste 101, Knoxville, TN 37922 Phone: 865-539-0270 | |
Jess Lee Stockton, Physician Assistant Medicare: Medicare Enrolled Practice Location: 123 Fox Rd, Knoxville, TN 37922 Phone: 865-342-5823 | |
Briana Roberts, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2001 Laurel Ave Ste 204, Knoxville, TN 37916 Phone: 865-673-0288 | |
Cynthia E. Simmons, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7211 Wellington Dr, Suite 101, Knoxville, TN 37919 Phone: 865-558-9822 |